– Debut on Nasdaq follows completion of the company’s business combination with Oaktree Acquisition Corp. II, which included a fully committed and upsized $175 million PIPE
Tag: Alvotech
Alvotech and STADA Pave Way resolve European Patent Dispute With AbbVie and launch UKYNDRA®(AVT02)
REYKJAVIK, Iceland & BAD VILBEL, Germany, 06.04.2022 – Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines
